AMERISAFE Inc (AMSF)

Currency in USD
30.03
-0.58(-1.89%)
Closed·
30.26+0.23(+0.77%)
·

AMSF Earnings

Latest Release
Jul 21, 2026
EPS / Forecast
0.44 / 0.52
Revenue / Forecast
85.97M / 85.09M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/0.503--/85.52M----Free Sign Up
2026/060.440/0.52085.97M/85.09M-15.38%+1.03%Free Sign Up
2026/030.500/0.55188.50M/90.49M-9.26%-2.2%Free Sign Up
2025/120.510/0.59081.50M/66.45M-13.56%+22.65%Free Sign Up
2025/090.720/0.56080.32M/78.69M+28.57%+2.07%Free Sign Up
2025/060.730/0.55081.10M/79.87M+32.73%+1.54%Free Sign Up
2025/030.600/0.61083.78M/84.49M-1.64%-0.84%Free Sign Up
2024/120.670/0.61362.70M/61.22M+9.25%+2.42%Free Sign Up
2024/090.580/0.58078.70M/71.53M0%+10.02%Free Sign Up
2024/060.580/0.63075.83M/70.65M-7.94%+7.33%Free Sign Up

All numbers in USD

AMERISAFE Inc Earnings Call Summary for Q2/2026

  • AMERISAFE Q2 operating EPS of $0.44 missed estimates by $0.08 (15.38%), while revenue of $85.97M beat forecasts by 1.03%; shares fell 4.8%.
  • Gross premiums written rose 7.9% to $86M, marking ninth consecutive quarter of growth with renewal retention above 93%.
  • Expense ratio increased to 31.8% from 31.3%, including $700K bad-debt write-off; current accident year loss ratio held at 72%.
  • Management expects mid-single-digit growth trajectory but cited intensifying competition, rate softening, and medical inflation pressures.
  • CEO Frost emphasized focus on profitable growth over volume; company generated 23.5% ROE and $7.3M favorable prior-year reserve development.
Last Updated: 2026-07-22, 11:16 a/m
Read Full Transcript

FAQ

What Is AMERISAFE's Earnings Per Share (TTM)?

The AMERISAFE EPS (TTM) is 2.48.

When Is The Next AMERISAFE Earnings Date?

AMERISAFE will release its next earnings report on Oct 28, 2026.

What Is AMERISAFE’s Revenue Forecasts For Upcoming Quarters?

AMERISAFE’s revenue forecast is 85.52M.

How Did AMERISAFE React to the Company's Latest Earnings Report?

AMERISAFE reported a -15.38% EPS surprise and a +1.03% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -9.16%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.